Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Adenuric, Feburic, Uloric, febuxostat (Adenuric - EU) (TMX-67)
print preview
bookmark
share with colleague
General Information
Company
Teijin Pharma Ltd.
Description
Non-purine selective inhibitor of xanthine oxidase
Molecular Target
Xanthine oxidase
Mechanism of Action
Xanthine oxidase inhibitor
Latest Stage of Development
Marketed
Indication
Hyperuricemia / gout
Partner
Astellas Pharma Inc.
;
Takeda Pharmaceutical Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy